January 12, 2008 -- During the past week, ChinaBio® Today published articles that ran along two major themes: broad overviews of China biotech and progress reports from individual companies. On the broad overview front, Dr. Charles C. Liu, a guest author, discussed proposed changes in China patent law, and eight researchers wrote a detailed analysis of biotech in China, while recommending changes that will improve growth. Among the individual companies reporting milestones, Unigene will establish a $30 million manufacturing joint venture in China; Sinobiomed received a 9 million RMB ($1.24 million) grant to conduct a Phase II trial of its malaria vaccine; Biosensors will complete its acquisition of the remaining 50% of fellow stent company JW Medical Systems Ltd; Calypte received GMP approval of its China manufacturing facility for its HIV diagnostic test; and Benda announced expanded manufacturing capability. More details....
